Nektar Therapeutics (NKTR) Receivables - Net (2016 - 2025)
Historic Receivables - Net for Nektar Therapeutics (NKTR) over the last 16 years, with Q3 2025 value amounting to $200000.0.
- Nektar Therapeutics' Receivables - Net changed N/A to $200000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $200000.0, marking a year-over-year change of. This contributed to the annual value of $1.2 million for FY2023, which is 7985.29% down from last year.
- Nektar Therapeutics' Receivables - Net amounted to $200000.0 in Q3 2025.
- Nektar Therapeutics' 5-year Receivables - Net high stood at $30.2 million for Q1 2022, and its period low was $200000.0 during Q3 2025.
- Over the past 5 years, Nektar Therapeutics' median Receivables - Net value was $6.0 million (recorded in 2022), while the average stood at $12.0 million.
- Its Receivables - Net has fluctuated over the past 5 years, first crashed by 9008.93% in 2023, then skyrocketed by 2076.79% in 2024.
- Quarter analysis of 5 years shows Nektar Therapeutics' Receivables - Net stood at $22.5 million in 2021, then tumbled by 73.41% to $6.0 million in 2022, then plummeted by 79.85% to $1.2 million in 2023, then fell by 0.75% to $1.2 million in 2024, then tumbled by 83.28% to $200000.0 in 2025.
- Its last three reported values are $200000.0 in Q3 2025, $1.2 million for Q2 2024, and $3.6 million during Q1 2024.